Cadian Capital Management, LP Jazz Pharmaceuticals PLC Transaction History

Cadian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $12.2 Million - $14.3 Million	-100,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$115.94 - $166.74 $11.6 Million - $16.7 Million	100,000 New	100,000 $12.4 Million
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $117 Million - $131 Million	-725,092 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$146.33 - $183.18 $71.2 Million - $89.1 Million	-486,497 Reduced 40.15%	725,092 $125 Million
Q1 2018 May 14, 2018	SELL	$135.59 - $157.16 $9.98 Million - $11.6 Million	-73,600 Reduced 5.73%	1,211,589 $183 Million
Q4 2017 Feb 13, 2018	BUY	$131.06 - $150.39 $13.9 Million - $16 Million	106,241 Added 9.01%	1,285,189 $173 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $168 Million - $183 Million	1,178,948	1,178,948 $172 Million

542

59M

125K

58.4K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Cadian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cadian Capital Management, LP with notifications on news.